{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:51:57Z","timestamp":1788951117578,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1124\/dmd.115.063776","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T03:21:12Z","timestamp":1433215272000},"page":"1254-1266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol"],"prefix":"10.1016","volume":"43","author":[{"given":"Hassan N.","family":"Althurwi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid H.","family":"Maayah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama H.","family":"Elshenawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman O.S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.115.063776_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/FJC.0b013e3182055baf","article-title":"Inhibition of soluble epoxide hydrolase confers cardioprotection and prevents cardiac cytochrome P450 induction by benzo(a)pyrene","volume":"57","author":"Aboutabl","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/dmd.115.063776_bib2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","article-title":"Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy","volume":"106","author":"Ai","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.115.063776_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/FJC.0000000000000036","article-title":"Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy","volume":"63","author":"Althurwi","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/dmd.115.063776_bib4","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/bph.12066","article-title":"Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy","volume":"168","author":"Althurwi","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.115.063776_bib5","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/nar\/19.9.2499","article-title":"A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells","volume":"19","author":"Andrews","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/dmd.115.063776_bib6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ijc.25054","article-title":"High-throughput detection of nuclear factor-kappaB activity using a sensitive oligo-based chemiluminescent enzyme-linked immunosorbent assay","volume":"127","author":"Bhattacharya","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1124\/dmd.115.063776_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1124\/dmd.115.063776_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.RES.78.3.415","article-title":"Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors","volume":"78","author":"Campbell","year":"1996","journal-title":"Circ Res"},{"key":"10.1124\/dmd.115.063776_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1157\/13087900","article-title":"[Cardiac hypertrophy: molecular and cellular events]","volume":"59","author":"Carre\u00f1o","year":"2006","journal-title":"Rev Esp Cardiol"},{"key":"10.1124\/dmd.115.063776_bib10","series-title":"The Canadian Heart Health Strategy: Risk Factors and Future Cost Implications","year":"2010"},{"key":"10.1124\/dmd.115.063776_bib11","doi-asserted-by":"crossref","first-page":"e92903","DOI":"10.1371\/journal.pone.0092903","article-title":"A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes","volume":"9","author":"Cox","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/dmd.115.063776_bib12","doi-asserted-by":"crossref","first-page":"H211","DOI":"10.1152\/ajpheart.00581.2007","article-title":"Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta","volume":"295","author":"Davel","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/dmd.115.063776_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1208\/s12248-012-9425-7","article-title":"Determination of the dominant arachidonic acid cytochrome p450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics","volume":"15","author":"El-Sherbeni","year":"2013","journal-title":"AAPS J"},{"key":"10.1124\/dmd.115.063776_bib14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bcp.2013.11.015","article-title":"Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy","volume":"87","author":"El-Sherbeni","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.115.063776_bib15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.pharmthera.2005.05.011","article-title":"Cytochrome P450 enzymes: central players in cardiovascular health and disease","volume":"112","author":"Elbekai","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.115.063776_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.prostaglandins.2006.05.003","article-title":"Epoxyeicosatrienoic acids, cell signaling and angiogenesis","volume":"82","author":"Fleming","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1124\/dmd.115.063776_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/dmd.104.002253","article-title":"tert-Butylhydroquinone is a novel aryl hydrocarbon receptor ligand","volume":"33","author":"Gharavi","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.063776_bib18","series-title":"The Growing Burden of Heart Disease and Stroke in Canada 2003","year":"2003"},{"key":"10.1124\/dmd.115.063776_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1124\/dmd.115.063776_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.107.130336","article-title":"20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells","volume":"324","author":"Ishizuka","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.115.063776_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1124\/dmd.115.063776_bib22","first-page":"e21","article-title":"Heart disease and stroke statistics\u20142009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1124\/dmd.115.063776_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.115.063776_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.vascn.2014.11.005","article-title":"Human fetal ventricular cardiomyocyte, RL-14 cell line, is a promising model to study drug metabolizing enzymes and their associated arachidonic acid metabolites","volume":"71","author":"Maayah","year":"2015","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/dmd.115.063776_bib25","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1242\/jcs.02674","article-title":"Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis","volume":"118","author":"Michaelis","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1124\/dmd.115.063776_bib26","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1096\/fj.02-0640fje","article-title":"Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR)","volume":"17","author":"Michaelis","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/dmd.115.063776_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1540\/jsmr.41.175","article-title":"Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system","volume":"41","author":"Miyata","year":"2005","journal-title":"J Smooth Muscle Res"},{"key":"10.1124\/dmd.115.063776_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ng.129","article-title":"Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease","volume":"40","author":"Monti","year":"2008","journal-title":"Nat Genet"},{"key":"10.1124\/dmd.115.063776_bib29","article-title":"Measurement of soluble epoxide hydrolase (sEH) activity","volume":"Chapter 4","author":"Morisseau","year":"2007","journal-title":"Curr Protoc Toxicol"},{"key":"10.1124\/dmd.115.063776_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/abio.2001.5395","article-title":"Liquid chromatographic-electrospray ionization-mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid","volume":"298","author":"Nithipatikom","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.115.063776_bib31","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1124\/dmd.115.063776_bib32","series-title":"Tracking Heart Disease and Stroke in Canada","year":"2009"},{"key":"10.1124\/dmd.115.063776_bib33","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1073\/pnas.111155798","article-title":"Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes","volume":"98","author":"Purcell","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.115.063776_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1471-4914(03)00114-X","article-title":"The molecular basis of myocardial hypertrophy and heart failure","volume":"9","author":"Ritter","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1124\/dmd.115.063776_bib35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1124\/dmd.115.063776_bib36","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.RES.0000139436.89654.c8","article-title":"Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42\/p44 MAPK pathway","volume":"95","author":"Seubert","year":"2004","journal-title":"Circ Res"},{"key":"10.1124\/dmd.115.063776_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","article-title":"Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function","volume":"43","author":"Spector","year":"2004","journal-title":"Prog Lipid Res"},{"key":"10.1124\/dmd.115.063776_bib38","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1096\/fj.02-0138com","article-title":"Testosterone, cytochrome P450, and cardiac hypertrophy","volume":"16","author":"Thum","year":"2002","journal-title":"FASEB J"},{"key":"10.1124\/dmd.115.063776_bib39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejps.2010.03.018","article-title":"Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs","volume":"40","author":"Tsai","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.115.063776_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.vph.2013.02.004","article-title":"Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line","volume":"58","author":"Tse","year":"2013","journal-title":"Vascul Pharmacol"},{"key":"10.1124\/dmd.115.063776_bib41","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"Xu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.115.063776_bib42","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0026-895X(24)23134-5","article-title":"Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells","volume":"60","author":"Yang","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.115.063776_bib43","doi-asserted-by":"crossref","first-page":"H37","DOI":"10.1152\/ajpheart.00983.2008","article-title":"Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity","volume":"297","author":"Zhang","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/dmd.115.063776_bib44","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.tiv.2009.12.002","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin and beta-naphthoflavone induce cellular hypertrophy in H9c2 cells by an aryl hydrocarbon receptor-dependant mechanism","volume":"24","author":"Zordoky","year":"2010","journal-title":"Toxicol In vitro"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624112834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624112834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.115.063776","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:30:06Z","timestamp":1739907006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624112834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0090955624112834"],"URL":"https:\/\/doi.org\/10.1124\/dmd.115.063776","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.115.063776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}